GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery

102Citations
Citations of this article
74Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

OBJECTIVE-Glucagon like peptide-1 (GLP-1) has been suggested as a major factor for the improved glucose tolerance ensuing after Roux-en-Y gastric bypass (RYGBP) surgery. We examined the effect of blocking endogenous GLP-1 action on glucose tolerance in subjects with sustained remission of type 2 diabetes mellitus (T2DM) present before RYGBP. RESEARCH DESIGN AND METHODS-Blood glucose, insulin, C-peptide, glucagon, GLP-1, and glucose-dependent insulinotropic peptide levels were measured after a meal challenge with either exendin-(9-39) (a GLP-1r antagonist) or saline infusion in eight subjects with sustained remission of T2DM after RYGBP and seven healthy controls. RESULTS-Infusion of exendin-(9-39) resulted in marginal deterioration of the 2-h plasma glucose after meal intake in RYGBP subjects [saline 78.4 ± 15.1 mg/dL compared with exendin-(9-39) 116.5 ± 22.3 mg/dL; P < 0.001]. Furthermore, glucose response to meal intake was similarly enlarged in the two study groups [percent change in the area under the curve of glucose exendin-(9-39) infusion versus saline infusion: controls 10.84 ± 8.8% versus RYGBP 9.94 ± 8.4%; P = 0.884]. In the RYGBP group, the blockade of the enlarged GLP-1 response to meal intake resulted in reduced insulin (P = 0.001) and C-peptide (P > 0.001), but no change in glucagon (P = 0.258) responses. CONCLUSIONS-The limited deterioration of glucose tolerance on blockade of GLP-1 action in our study suggests the resolution of T2DMafter RYGBP may be explained bymechanisms beyond enhancement of GLP-1 action. © 2013 by the American Diabetes Association.

Cite

CITATION STYLE

APA

Jiménez, A., Casamitjana, R., Viaplana-Masclans, J., Lacy, A., & Vidal, J. (2013). GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery. Diabetes Care, 36(7), 2062–2069. https://doi.org/10.2337/dc12-1535

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free